Wither Social Media?

Researchers apply epidemiological approaches to model user adoption and abandonment of sites like Facebook.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, TYCHAYIf signing up for a Facebook account were like being infected by a disease-causing pathogen, then abandoning the social networking site would be like recovering from the illness, two Princeton University engineers propose in a preprint posted to arXiv last week (January 17). John Cannarella and Joshua Spechler applied epidemiological approaches to model and analyze the dynamics of user adoption and abandonment of social networking sites “by drawing analogy to the dynamics that govern the spread of infectious disease,” they wrote.

The duo applied a modified SIR—susceptible, infected, removed—model of disease spread to Google search query data for “Facebook,” as a proxy for user interest in Facebook, finding evidence to suggest that the social networking site is at the onset of an abandonment phase. According to Cannarella and Spechler, extrapolating the search data on the modified disease-spread model “predicts a rapid decline in Facebook activity in the next few years.”

(Hat tip: Big Think)

Update (January 23): Facebook data scientist Mike Develin has questioned the authors’ analytical methods and conclusions, noting in jest that, according to page “likes,” his team’s “research unequivocally demonstrated that Princeton may be in danger of disappearing entirely.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies